Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Total 13F shares
-
57,567,548
-
Share change
-
+2,630,881
-
Total reported value
-
$495,653,323
-
Put/Call ratio
-
4.4%
-
Price per share
-
$8.61
-
Number of holders
-
131
-
Value change
-
+$24,341,050
-
Number of buys
-
84
-
Number of sells
-
47
Institutional Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q3 2022
As of 30 Sep 2022,
Kezar Life Sciences Inc - COMMON-STOCK (KZR) was held by
131 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,567,548 shares.
The largest 10 holders included
Avidity Partners Management LP, BlackRock Inc., STATE STREET CORP, SUVRETTA CAPITAL MANAGEMENT, LLC, Bellevue Group AG, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, VICTORY CAPITAL MANAGEMENT INC, ORBIMED ADVISORS LLC, and CHI Advisors LLC.
This page lists
131
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.